The significance of platelet counts in coagulation studies

Journal of Medicine

Volumn 32, Issue 1-2, 2001, Pages 83-96

  Carroll, W E ^a   Wollitzer, A O ^b   Harris, L ^a   Ling, M C C ^a   Whitaker, W L ^a   Jackson, R D ^c  

^a SANTA BARBARA COTTAGE HOSPITAL   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

Coagulation; Heparin; Phospholipid; Platelet

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PHOSPHOLIPID ANTIBODY; THROMBOCYTE FACTOR 4;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MONITORING; HEPARINIZATION; HUMAN; HUMAN CELL; INTERNATIONAL STANDARD UNIT; MEASUREMENT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOCYTE COUNT;

BLOOD COAGULATION TESTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROTHROMBIN TIME;

EID: 0035041548     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Adcock, D., Kressin, D. and Marlar, R.A. (1998).: The effect of time and temperature variables on routine coagulation tests. Blood, Coagulation Fibrinolysis 9: 463-470.
2. Betterle, C., Fabris, F., deMarco, L., Del Prete, G.F. and Girolami, A. (1977).: Clotting factors and platelets. Haemostasis 6: 171-179.
3. Biggs, R. and MacMillan, R.L. (1948).: The errors of some haematological methods as they are used in a routine laboratory. J. Clin. Path. 1:269-287.
4. Bland, J.M. and Altman, D.G. (1986).: Statistical methods for assessing agreement between two different methods of clinical measurement. Lancet 1: 307-310.
5. Bounameaux, Y. (1957).: Dosage des facteurs de coagulation contenus dans l'atmosphère plasmatique des plaquettes humaines. Rev. Franc. Etudes Clin, et Biol. 2: 52-63.
6. Brecher, G., Schneiderman, M. and Cronkite, E.P. (1953).: Reproducibility and constancy of the platelet count. J. Clin. Pathol. 23: 15-26.
7. Brigden, M.L., Graydon, C., McLeod, B. and Lesperance, M. (1997).: Prothrombin time determination. The lack of need for a discard tube and 24-hour stability. Am. J. Clin. Pathol. 108: 422-426.
8. Brinkhous, K.M. (1939).: A study of the clotting defect in hemophilia: the delayed formation of thrombin. Am. J. Med. Sci. 198: 509-516.
9. Dameshek, W. (1932).: A method for the simultaneous enumeration of blood platelets and reticulocytes. Arch. Int. Med. 50: 579-589.
10. Fantl, P. and Ward, H.A. (1958).: The thromboplastic component of intact blood platelets is present in masked form. Austral. J. Exp. Biol. 36: 499-504.
11. Gulati, G.L., Asselta, A and Chen, C. (1997).: Using a vortex to disaggregate platelet clumps. Laboratory Medicine 28: 665-667.
12. Hirsh, J., vanAken, W.G., Gallus, A.S., Dollery, C.T., Cade, J.F. and Yung, W.L. (1976).: Heparin Kinetics in Venous Thrombosis and Pulmonary Embolism. Circulation 53: 691-695.
13. Huseby, R.M. and Shafer, D. (1978).: Variables and questions related to a recent comparative heparin response. Am. J. Clin. Pathol. 69: 99-100.
14. Koepke, J.A., Rodgers, J.L. and Olliver, M.T. (1975).: Pre-instrumental variables in coagulation testing. Am. J. Clin. Pathol. 64: 591-596.
15. The National Committee for Clinical Laboratory Standards. (NCCLS), (1998).: Collection, transport and processing of blood specimens for coagulation testing and general performance of coagulation assays; approved guideline - Third Edition. H21-A3, 18: 4-5.
16. Opitz, H. and Zweig, H. (1924).: Die hämophilie kein örtliches Gerinnungsproblem sondern eine universellere konstitutionelle Frage. Jahrbuch f. Kinderheilkunde. 107: 155-174.
17. Triplett, D.A., Brandt, J.T., Kaczor, D. and Schaeffer, J. (1983).: Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am. J. Clin. Pathol. 79: 678-682.